Efficacy and Safety of GLP-1RAs with or without Baseline SGLT2i: Post-hoc Analysis of the SUSTAIN 10 Trial

被引：0
|
作者：
Capehorn, Matthew
Catarig, Andrei-Mircea
Frenkel, Ofir
Hindsberger, Charlotte
Marre, Michel
Price, Hermione
Pratley, Richard E.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-647-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
647-P
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    DIABETOLOGIA, 2018, 61 : S369 - S370
  • [32] The impact of ethnicity on efficacy of DPP4I, SGLT2I and GLP-1RA: A systematic review and meta-analysis of randomised controlled trials
    Gan, S.
    Dawed, A. Y.
    Donnelly, L.
    Nair, A. T. N.
    Mohan, V.
    Pearson, E. R.
    DIABETIC MEDICINE, 2020, 37 : 178 - 179
  • [33] DPP4-i/SGLT-2i combination as add-on to metformin for type 2 diabetes mellitus: comparison to OADs, GLP-1RAs or basal insulin
    Qin, L.
    Orme, M. E.
    Varol, N.
    Kalkan, A.
    Erdmann, M.
    Bell, K.
    Mukherjee, J.
    DIABETOLOGIA, 2016, 59 : S94 - S94
  • [34] Safety and Efficacy of Apixaban Versus Enoxaparin/Warfarin in Patients with Extremes of Body Weight: Post-Hoc Analysis of the AMPLIFY Trial
    Lee, Theodore
    Pan, Sharon
    Byon, Wonkyung
    Ilyas, Bushra S.
    BLOOD, 2019, 134
  • [35] EFFICACY AND SAFETY PROFILE OF IVABRADINE IN HEART FAILURE DUE TO CHAGAS' HEART DISEASE: A POST-HOC ANALYSIS OF THE SHIFT TRIAL
    Bocchi, Edimar Alcides
    Guimaraes, Guilherme
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 922 - 922
  • [36] Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial
    Vamos, M.
    Calkins, H.
    Kowey, P. R.
    Torp-Pederson, C. T.
    Genti, V. Corp Dit
    Wieloch, M.
    Koren, A.
    Hohnloser, S. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 627 - 627
  • [37] The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials
    Kato, Masaki
    Masuda, Takahiro
    Sano, Fumiya
    Kato, Tadafumi
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 337 : 150 - 158
  • [38] Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
    Cherney, David Z. I.
    Hadjadj, Samy
    Lawson, Jack
    Mosenzon, Ofri
    Tuttle, Katherine
    Vrhnjak, Blaz
    Rasmussen, Soren
    Bain, Stephen C.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2345 - 2355
  • [39] Efficacy of risankizumab versus ustekinumab by baseline Crohn's Disease location: post-hoc analysis of the SEQUENCE head-to-head trial
    Peyrin-Biroulet, L.
    Colombel, J. F.
    D'Haens, G.
    Dubinsky, M.
    Cao, Q.
    Kligys, K.
    Garrison, A.
    Huang, X.
    Neimark, E.
    Anschutz, T.
    Crowley, J.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I104 - I105
  • [40] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Miao Yu
    Guo Yue Yuan
    Bin Zhang
    Hai Ya Wu
    Xiao Feng Lv
    Diabetes Therapy, 2020, 11 : 1147 - 1159
12345